Anemone study: prevalence of risk factors for superficial vein thrombosis in a large Italian population of blood donors

Fcsa,; Tiscia, Giovanni Luca; Ostuni, Angelo; Mauro, Lazzaro Di; Mastroianno, Mario; Coffetti, Nadia; Dovigo, Roberto; Meneghini, Giovanna; Turrini, Anna; Cavallero, Giobatta; Cappucci, Filomena; Vergura, Patrizia; Laurenzo, Antonio De; Tosetto, Alberto; Margaglione, Maurizio

doi:10.1007/s11239-020-02140-5

Cited by 1 publication

(2 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3-19.5). The study revealed that low-risk individuals share the same risk factors for SVT as those in secondary care [14].…”

Section: Epidemiologymentioning

confidence: 89%

“…The frequent underestimation and the misconception about the hazard of SVT in general practice probably prevented epidemiological studies [7][8][9][10][11][12][13][14] from accurately identifying the incidence and prevalence of SVT in the general population. As previously discussed, SVT should not be considered a benign disease.…”

Section: Discussion and Future Directionsmentioning

confidence: 99%

See 1 more Smart Citation

Superficial Venous Thrombosis: A Comprehensive Review

Mangiafico,

Costanzo

2024

Healthcare

View full text Add to dashboard Cite

Superficial venous thrombosis (SVT), an inflammatory–thrombotic process of a superficial vein, is a relatively common event that may have several different underlying causes. This phenomenon has been generally considered benign, and its prevalence has been historically underestimated; the estimated incidence ranges from about 0.3 to 1.5 event per 1000 person-years, while the prevalence is approximately 3 to 11%, with different reports depending on the population studied. However, such pathology is not free of complications; indeed, it could extend to the deep circulation and embolize to pulmonary circulation. For this reason, an ultrasound examination is recommended to evaluate the extension of SVT and to exclude the involvement of deep circulation. Also, SVT may be costly, especially in the case of recurrence. Therefore, accurate management is necessary to prevent sequelae and costs related to the disease. This review aims to analyse the epidemiology of SVT, its complications, optimal medical treatment, and open questions with future perspectives.

show abstract

“…3-19.5). The study revealed that low-risk individuals share the same risk factors for SVT as those in secondary care [14].…”

Section: Epidemiologymentioning

confidence: 89%